Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
China Evergrande Seeks U.S. Court Approval for $19 Billion Debt Restructuring
China Evergrande Group is seeking a U.S. court’s approval to restructure more than $19 billion in the company’s offshore debts, as the embattled property developer
AMC Can Sell Nearly 400 Million New Shares Following Court Approval
Distressed movie-theater chain overcame opposition from meme investors concerned about dilution, winning court approval for transactions to sell more shares. Source link
Cruise, Waymo Get Approval to Expand Driverless Vehicles in San Francisco
California regulator votes to allow autonomous car companies to add cars and charge for rides. Source link
Analysis-Partnering with Coinbase could hinder bid for bitcoin ETF approval By Reuters
© Reuters. FILE PHOTO: Smartphone with displayed Coinbase logo and representation of cryptocurrencies are placed on a keyboard in this illustration taken, June 8, 2023.
Pakistan optimistic of securing IMF approval for $3 billion bailout By Reuters
2/2 © Reuters. FILE PHOTO: A trader shows U.S. dollar notes at a currency exchange booth in Karachi, Pakistan December 3, 2018. REUTERS/Akhtar Soomro//File Photo
EU fines Illumina €432M for completing Grail acquisition without approval By Investing.com
© Reuters EU fines Illumina (ILMN) €432M for completing Grail acquisition without approval The European Commission has fined Illumina (NASDAQ:) approximately €432 million ($476.2M) for
Broadcom wins conditional EU antitrust approval to buy VMware By Reuters
© Reuters. FILE PHOTO: A smartphone with a displayed Broadcom logo is placed on a computer motherboard in this illustration taken March 6, 2023. REUTERS/Dado
FDA Approval Isn't Always a Happy Day for Biotech Investors
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link
Biogen stock whipsaws despite FDA granting full approval for Alzheimer’s drug; analysts explain why By Investing.com
© Reuters. FDA converts Biogen and Eisai’s Alzheimer’s treatment to traditional approval The U.S. Food and Drug Administration (FDA) converted the approval status of Leqembi
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug By Reuters
© Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File